Petrylak Provides Insight Into Testing, Multidisciplinary Management in Prostate and Bladder Cancer

Welcome to OncLive On Air^®! I’m your host today, Caroline Seymour.

OncLive On Air^® is a podcast from OncLive^®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive^® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, we had the pleasure of speaking with Daniel P. Petrylak, MD, a professor of medical oncology and urology, the chief of Genitourinary Oncology, and a co-leader of Cancer Signaling Networks at Yale Cancer Center, as well as the 2017 Giants of Cancer Care^® award winner for genituorinary cancers.

In our exclusive interview, Dr Petrylak discussed current issues with genetic testing and disease management in prostate and bladder cancer, including the difficulties that arise when obtaining tissue samples and deciding when to do testing. He also explained some of the reasons for poor testing rates and emphasized the importance of proper multidisciplinary management during testing and when seeking to mitigate adverse effects.

Additionally, Dr Petrylak discussed intriguing results regarding the combination of abiraterone acetate (Zytiga) and olaparib (Lynparza) in prostate cancer, and shared how organizations such as Fans for the Cure are raising awareness about the importance of early cancer testing and helping to alleviate diagnostic disparities.

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air^®. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive^® is also on social media. On Twitter, follow us at @OncLive and @OncLiveSOSS. On Facebook, like us at OncLive and OncLive State of the Science Summit and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air^®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air^®.

*OncLive On Air^® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.